The April report showed shrinkage in a few areas. Chest: There is improvement of the RUL subpleural groundglass opacity, measuring 6 mm, previously 9 mm. The 4 mm RLL subpleural nodule was unchanged. Bones: The right third rib measures 4.8 cm x 2.5 cm, previously 5.3 cm x 3.4 cm. The left pelvic lesion measures 4 to 3 x 2.2, previously 4.1 cm x 3 cm. The right 3rd rib and left pelvic reference lesions exhibit interval decrease of its soft tissue tumor component. Impression: 1. Osseous metastatis disease in the right third rib and the left pelvis which shows improvement compared to prior study. 2. Interval improvement of RUL ground glass opacity.
Okay, so there is shrinkage as listed, BUT what about the other areas of bone. No news about the 6th rib and no news on T7 or T8. It's a small improvement, and I consider his cancer stable with this latest report. Honestly, I was hoping for a better response from this drug. Hopefully, the next report shows even more shrinkage!
The side effects from this drug are mild, but he still has issues with eating. Food doesn't taste good, and sometimes just the smell makes it were he doesn't want to eat. He had the same thing happen when he was on Nexavar. I just hope he doesn't lose as much weight as he did when he was on that drug.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.